Eric Meng

Eric Meng

Auto-generated profile, based on publicly available information

Eric Meng

Department of Medicine, University of British Columbia, Vancouver, BC

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
EMEric Meng
Eric Meng
SJStephanie M. Jiang
Stephanie M. Jiang
TSTherese Servito
Therese Servito
DPDarrin Payne
Darrin Payne
MEMohammad El-Diasty
Mohammad El-Diasty

2 February 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
NSNicola Symonds
Nicola Symonds
EMEric X M Meng
Eric X M Meng
JBJohn Gordon Boyd
John Gordon Boyd
TBTracy Boyd
Tracy Boyd
ADAndrew Day
Andrew Day
JMJohn Muscedere
John Muscedere
Background Critically ill patients are at high risk of acquiring ventilator-associated pneumonia (VAP), which occurs in approximately 20% of mechanically ventilated patients. VAP results either from aspiration of pathogen-contaminated oropharyngeal secretions or contaminated biofilms that form on endotracheal tubes (ETTs) after intubation. VAP results in increased duration of mechanical ventilation, increased intensive care unit and hospital length of stay, increased risk of death and increased healthcare costs. Because of its impact on patient outcomes and the healthcare system, VAP is regarded as an important patient safety issue and there is an urgent need for better evidence on the efficacy of prevention strategies. Modified ETTs that reduce aspiration of oropharyngeal secretions with subglottic secretion drainage or reduce the occurrence of biofilm with a coating of ceragenins (CSAs) are available for clinical use in Canada. In this implementation study, we will evaluate the efficacy of these two types of Health Canada-licensed ETTs on the occurrence of VAP, and impact on patient-centred outcomes. Methods In this ongoing, pragmatic, prospective, longitudinal, interrupted time, cross-over implementation study, we will compare the efficacy of a CSA-coated ETT (CeraShield N8 Pharma) with an ETT with subglottic secretion drainage (Taper Guard, Covidien). The study periods consist of four alternating time periods of 11 or 12 weeks or a total of 23 weeks for each ETT. All patients intubated with the study ETT in each time period will be included in an intention-to-treat analysis. Outcomes will include VAP incidence, mortality and health services utilisation including antibiotic use and length of stay. Ethics and dissemination This study has been approved by the Health Sciences Research Ethics Board at Queen’s University. The results of this study will be actively disseminated through manuscript publication and conference presentations. Trial registration number NCT05761613.

2 March 2023 in JACC: Case Reports
Verified
Journal Article
Open access
EMEric Meng
Eric Meng
MSMaria Servito
Maria Servito
AAAnood Alqaydi
Anood Alqaydi
YGYannis Amador Godoy
Yannis Amador Godoy
DPDarrin Payne
Darrin Payne
MEMohammad El-Diasty
Mohammad El-Diasty
Transcatheter aortic valve implantation is now a validated treatment option for severe aortic stenosis in patients in whom surgical aortic valve replacement is recommended, especially those associated with an elevated surgical risk. Here, we discuss the surgical management of a case of severe aortic stenosis in a patient with huge Morgagni hernia. (Level of Difficulty: Beginner.)

24 June 2026 in Ultrasound Quarterly
Verified
Journal Article
Closed access
EMEric Meng
Eric Meng
KBKirun Baweja
Kirun Baweja
CWClaire Weersink
Claire Weersink
MAMonish Ahluwalia
Monish Ahluwalia
WHWilma Hopman
Wilma Hopman
SMSteven J. Montague
Steven J. Montague
Splenomegaly is an important clinical sign associated with diverse pathologies. Traditional bedside physical examination maneuvers used to detect splenomegaly demonstrate poor diagnostic performance. Point-of-care ultrasound (POCUS) is a potential alternative. We sought to compare the diagnostic performance of structured physical examination maneuvers and POCUS in the bedside detection of splenomegaly. Internal medicine and hematology inpatients at Kingston Health Sciences Centre from February 2023 to June 2024 were prospectively enrolled. Participants underwent a structured physical exam comprised of Castell’s Method, Traube’s Method, Nixon’s Method, and one-handed palpation followed by a POCUS examination. Radiographic confirmation of splenomegaly (spleen length >12 cm) was obtained via abdominal ultrasound, computed tomography, or magnetic resonance imaging within 1 month of enrollment. The performance of each diagnostic test was determined. Of 130 patients enrolled, 55 (38.5%) had radiographically confirmed splenomegaly. POCUS demonstrated higher diagnostic performance (sensitivity 70.9%, specificity 72.0%, Matthew’s correlation coefficient 0.43) compared with physical exam maneuvers. The most specific physical exam maneuver was Nixon’s method (90.8%), while percussion of Traube’s space had the highest sensitivity (52.7%). POCUS measurements strongly correlated with formal imaging (Spearman rho=0.630; P <0.001). The diagnostic accuracy of POCUS was reduced in patients with elevated body mass index ( P =0.027) and in those scanned within 2 hours of eating ( P =0.047). The POCUS examination took almost twice as long as the combined physical exam maneuvers (median 142 vs. 82). POCUS outperforms traditional physical examination in detecting splenomegaly and correlates well with formal imaging, supporting its integration into bedside practice and medical education.